Advancement in preoperative desensitization therapy for ABO incompatible kidney transplantation recipients
Transplant Immunology · 2023-10 · 80 · 101899
DOI: 10.1016/j.trim.2023.101899 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transplant Immunology, 2023-10. Verfasst von Yuhua Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Hospital of Lanzhou University, Lanzhou, China; Gansu Province Clinical Research Center for Urology, Lanzhou, China…. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 107 Literaturangaben. Gefördert von: Science and Technology Department of Gansu Province.
Abstract (Originalsprache)
ABO incompatibility has long been considered an absolute contraindication for kidney transplantation. However, with the increasing number of patients with ESRD in recent years, ABO-incompatible kidney transplantation (ABOi-KT) has expanded the types of donors by crossing the blood group barrier through preoperative desensitization therapy. At present, the desensitization protocols consist of removal of preexisting ABO blood group antibody titers and prevention of ABO blood group antibody return. Studies have suggested similar patient and graft survival among ABOi-KT and ABOc-KT recipients. In this review, we will summarize the effective desensitization regimens of ABOi-KT, aiming to explore effective ways to improve the success rate and the long-term survival rate of ABOi-KT recipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Second Hospital of Lanzhou University, Lanzhou, China; Gansu Province Clinical Research Center for Urology, Lanzhou, China; Second Clinical School, Lanzhou University, Lanzhou, China.
- Department of Urology, The Second Hospital of Lanzhou University, Lanzhou, China; Gansu Province Clinical Research Center for Urology, Lanzhou, China.
- Department of Urology, The Second Hospital of Lanzhou University, Lanzhou, China; Gansu Province Clinical Research Center for Urology, Lanzhou, China; Second Clinical School, Lanzhou University, Lanzhou, China. Electron…
Förderung
- Science and Technology Department of Gansu Province
Zitieren
APA
Ma, Y., Man, J., Gui, H., Niu, J., & Yang, L. (2023). Advancement in preoperative desensitization therapy for ABO incompatible kidney transplantation recipients. Transplant Immunology, 80, 101899. https://doi.org/10.1016/j.trim.2023.101899
Vancouver
Ma Y, Man J, Gui H, Niu J, Yang L. Advancement in preoperative desensitization therapy for ABO incompatible kidney transplantation recipients. Transplant Immunology. 2023;80:101899. doi:10.1016/j.trim.2023.101899
BibTeX
@article{Ma2023,
author = {Ma, Yuhua and Man, Jiangwei and Gui, Huiming and Niu, Jiping and Yang, Li},
title = {Advancement in preoperative desensitization therapy for ABO incompatible kidney transplantation recipients},
journal = {Transplant Immunology},
year = {2023},
volume = {80},
pages = {101899},
doi = {10.1016/j.trim.2023.101899}
}
EUVIMED